Jeffrey L. Wade - Jul 8, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
President and COO
Signature
/s/ Jeffrey L. Wade
Stock symbol
LXRX
Transactions as of
Jul 8, 2024
Transactions value $
$0
Form type
4
Date filed
7/8/2024, 05:27 PM
Previous filing
Feb 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +307K $0.00 307K Jul 8, 2024 Common Stock 307K $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.